Why Choose Us?
Prescription weight management benefits from careful screening and ongoing medical oversight. The G Spa's treatment approach can focus on eligibility, dosing, response, and lifestyle factors.
Your provider reviews medical history, medications, weight-management goals, and conditions that could affect treatment suitability.
Phentermine and topiramate work through different mechanisms. The combination is designed to support weight reduction when used with diet and physical activity.
Qsymia is available in multiple strengths, and dosing is generally started low and adjusted according to the prescribing information and clinical response.
Visits can address weight change, tolerability, blood pressure, mood or cognitive symptoms, and other relevant health considerations.
Medication is intended to work alongside nutrition and physical activity, not replace them.
Benefits
Potential benefits of a medically supervised Phentermine and Topiramate Treatments treatment may include:
Prescription support for long-term weight management in eligible patients
A combination medication with two active ingredients that have complementary mechanisms
A structured dosing approach that can be adjusted according to response and tolerability
Clinical follow-up to assess weight change and medication-related concerns
Support for combining medication with a reduced-calorie eating plan and physical activity
An option that may be considered when a clinician determines combination pharmacotherapy is appropriate
Phentermine and topiramate may be considered for certain adults with obesity or adults who are overweight with at least one weight-related comorbid condition, when the specific treatment is clinically appropriate. Eligibility is not based on weight alone. Qsymia is contraindicated during pregnancy, with glaucoma, hyperthyroidism, use of monoamine oxidase inhibitors within the specified period, and known hypersensitivity to its components. The medication also carries important warnings related to fetal harm, mood changes, eye problems, metabolic effects, and other risks. A full medical assessment is therefore essential before treatment.
| Potentially Suitable For | A Consultation Is Important If You Have |
|---|---|
| Adults who meet the eligibility criteria for Qsymia | Pregnancy, plans for pregnancy, or potential pregnancy |
| Adults with obesity or qualifying overweight with a weight-related condition | Glaucoma or hyperthyroidism |
| Patients able to attend follow-up and follow prescribed dosing | Use of an MAOI within the previous 14 days |
| Patients seeking prescription support alongside diet and physical activity | Known hypersensitivity to phentermine, topiramate, or other Qsymia ingredients |
| Patients willing to report changes in mood, vision, cognition, or other symptoms | Significant kidney, liver, cardiovascular, psychiatric, or metabolic concerns requiring medication-specific assessment |
Treat Yourself To The Glow Up You Deserve at The G Spa.
Save up to $300
$10/Unit for teachers and nurses
1 Treatment - $399
Treatment Journey
Your Phentermine and Topiramate Treatments treatment begins with a medical evaluation and continues with scheduled monitoring. The exact plan depends on the prescribed product, dose, response, and health factors.
Your provider reviews your weight history, health conditions, medications, allergies, lifestyle factors, and treatment goals. Relevant measurements are assessed to determine whether prescription weight-management treatment is appropriate.
The provider screens for contraindications and important risk factors, including pregnancy potential, glaucoma, hyperthyroidism, medication interactions, and relevant psychiatric or ophthalmic history.
Current Qsymia prescribing information begins adults at 3.75 mg/23 mg once daily for 14 days, followed by 7.5 mg/46 mg once daily. Further changes depend on treatment response and the prescribing information. Do not alter the dose without medical direction.
Follow-up can include reviewing weight change, blood pressure, sleep, mood, cognitive symptoms, side effects, and other relevant measures. Your provider can determine whether treatment should continue, change, or stop.
Weight management may involve continued medication, nutrition, physical activity, and periodic reassessment. If a higher Qsymia dose is discontinued, the prescribing information recommends gradual tapering rather than abrupt cessation.
Google Reviews
Hear directly from patients about their experiences with The G Spa team, treatments, and locations.
Visit Us
Conveniently located in Santa Barbara and Los Olivos, The G Spa offers aesthetic treatments and personalized care at both locations.
Already a G Spa patient? Use our online booking system to schedule your next appointment quickly and conveniently.
Tell us what you are interested in and which location works best for you. A member of our team will follow up with you about your appointment request.
"*" indicates required fields
Blogs
Get helpful information about aesthetic treatments, skin care, injectables, lasers, and other services offered at The G Spa.
FAQ's
Phentermine and topiramate extended-release, sold as Qsymia, is an FDA-approved prescription combination used with a reduced-calorie diet and increased physical activity for long-term weight management in eligible patients with obesity or qualifying overweight.
Phentermine is a sympathomimetic amine anorectic, while topiramate affects several neurological pathways. Together, the combination can reduce appetite and food intake in some patients. The exact response varies by individual.
Qsymia is taken orally once daily in the morning. The FDA prescribing information starts adults at a lower dose and uses a stepwise approach based on response and tolerability. Your prescriber will determine the appropriate regimen.
Common adverse reactions in adults include paresthesia, dizziness, dysgeusia, insomnia, constipation, and dry mouth. Qsymia also has important warnings involving pregnancy, mood, cognition, eyes, metabolic changes, and other risks that should be reviewed with your clinician.
Qsymia is contraindicated in pregnancy, glaucoma, hyperthyroidism, use of monoamine oxidase inhibitors within 14 days, and known hypersensitivity to its components. A clinician should also review other health conditions and medications before prescribing.
Qsymia is indicated for long-term weight management in eligible patients, but duration is individualized. The prescribing clinician evaluates response, tolerability, and ongoing medical need. Do not stop higher-dose Qsymia abruptly because tapering is recommended to reduce seizure risk.